Bank of New York Mellon Corp - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 62 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$2,545,886
+40.4%
146,568
+13.8%
0.00%
Q2 2023$1,813,195
+31.7%
128,778
+0.6%
0.00%
Q1 2023$1,376,743
-27.8%
127,950
+0.5%
0.00%
Q4 2022$1,907,658
+18.3%
127,347
+1.4%
0.00%
Q3 2022$1,612,000
+37.8%
125,528
+4.1%
0.00%
Q2 2022$1,170,000
-14.2%
120,637
-11.9%
0.00%
Q1 2022$1,363,000
-13.5%
137,001
+2.3%
0.00%
Q4 2021$1,576,000
+2.5%
133,906
-0.8%
0.00%
Q3 2021$1,537,000
-16.1%
134,997
+2.8%
0.00%
Q2 2021$1,831,000
-26.4%
131,359
-2.3%
0.00%
-100.0%
Q1 2021$2,489,000
+2.9%
134,415
-1.8%
0.00%0.0%
Q4 2020$2,418,000
+73.6%
136,863
+50.5%
0.00%
Q3 2020$1,393,000
-29.5%
90,954
+17.3%
0.00%
-100.0%
Q2 2020$1,975,000
+164.4%
77,517
+60.8%
0.00%
Q1 2020$747,000
+45.9%
48,222
+4.3%
0.00%
Q4 2019$512,000
+15.1%
46,224
-11.5%
0.00%
Q3 2019$445,000
-41.8%
52,213
-7.4%
0.00%
Q2 2019$764,000
-9.9%
56,371
+20.1%
0.00%
Q1 2019$848,000
+46.7%
46,944
+128.2%
0.00%
Q4 2018$578,000
+32.9%
20,570
+20.5%
0.00%
Q3 2018$435,00017,0710.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q2 2019
NameSharesValueWeighting ↓
VHCP Management II, LLC 639,230$11,091,0003.32%
Boxer Capital, LLC 1,172,700$20,346,0002.30%
Sofinnova Investments, Inc. 1,845,400$32,018,0002.04%
Hillhouse Capital Management 5,736,527$99,529,0001.70%
Cormorant Asset Management, LP 831,000$13,842,0001.02%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,226,890$21,287,0000.75%
Foresite Capital Management IV, LLC 94,477$1,639,0000.56%
Vivo Capital, LLC 186,073$3,228,0000.42%
Baker Brothers Advisors 3,000,000$52,050,0000.39%
DC Investments Management, LLC 30,817$535,0000.34%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders